Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70280 |
KB-R7785
|
||
KB-R7785 is a novel ADAM12 and MMP inhibitor, ameliorating cardiac function in a transverse aortic constriction (TAC) model by inhibiting the proteolytic activation of HB-EGF signaling, exerting its antidiabetic effect by ameliorating insulin sensitivity through the inhibition of TNF-alpha production. | |||
T70279 |
Cotadutide
|
||
Cotadutide is a dual receptor agonist that modifies the activity of glucagon and glucagon-like peptide-1 (GLP-1). |